NOVEL SELECTIVE CYP11B1 INHIBITORS
The corticosteroid cortisol is synthesized in the adrenal cortex by a complex reaction cascade. The final step of the cortisol synthesis is catalyzed by CYP11B1. Due to the involvement of cortisol in many physiological processes a pathological overproduction might result in different diseases.
Scientist of Saarland University have now managed to develop the first CYP11B1 inhibitors showing a selective effect, i.e. they are effective on CYP11B1 nearly exclusively. Moreover the new inhibitors act with a very high degree of efficiency.
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-6340
Contact
Dr. Annekathrin Seifert (Dipl.-Chem.), Dipl.-Kfm. Axel Koch (MBA), Dr. Hauke Studier (Dipl.-Phys.)
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Red light therapy for repairing spinal cord injury passes milestone
Patients with spinal cord injury (SCI) could benefit from a future treatment to repair nerve connections using red and near-infrared light. The method, invented by scientists at the University of…
Insect research is revolutionized by technology
New technologies can revolutionise insect research and environmental monitoring. By using DNA, images, sounds and flight patterns analysed by AI, it’s possible to gain new insights into the world of…
X-ray satellite XMM-newton sees ‘space clover’ in a new light
Astronomers have discovered enormous circular radio features of unknown origin around some galaxies. Now, new observations of one dubbed the Cloverleaf suggest it was created by clashing groups of galaxies….
